Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EURIDIS: Dronedarone for Maintenance of Sinus Rhythm in AF/AFL
NCT00259428Phase 3Completed
- Sponsor
- Sanofi
- Start
- Nov 2001
- Primary completion
- Aug 2003
- Modality
- Small Molecules
- Countries
- 12
01
Overview
Phase 3, randomised, double-blind trial in Atrial fibrillation (AFib) and atrial flutter (AFL) comparing Dronedarone with Placebo (2 arms). Primary endpoint: Time from randomization to first documented AF/AFL recurrence at 12 months. Started Nov 2001; status: completed.
02
Drugs
dronedarone
03
Conditions
Atrial fibrillation (AFib)atrial flutter (AFL)
Beyond the preview
Go deeper on NCT00259428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00259428.